Nidlegy Phase III PIVOTAL trial shows postive results for patients with locally advanced fully…
Intratumoral Nidlegy followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alone
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Philogen
Sun Pharma, Philogen sign pact to commercialise specialty product, NIDLEGY in Europe, Australia and…
Nidlegy, currently in Phase III clinical trials, is a new anti-cancer biopharmaceutical which is being developed by Philogen for…